Cancer therapy – molecular targets in tumour–host interactions

Por Kurschat, P, Mauch, C
Publicado em 2006

Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis?

Por Hanselmann, C, Mauch, C, Werner, S
Publicado em 2001

Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderm...

Por Eckes, B, Mauch, C, Hüppe, G, Krieg, T
Publicado em 1996

Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic humaneratinocytes

Por Baumann, P, Zigrino, P, Mauch, C, Breitkreutz, D, Nischt, R
Publicado em 2000

Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with Bexarotene

Por Zhang, X., Schlaak, M., Fabri, M., Mauch, C., Kurschat, P.
Publicado em 2012

Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing.

Por Madlener, M, Mauch, C, Conca, W, Brauchle, M, Parks, W C, Werner, S
Publicado em 1996

Selective loss of PMA-stimulated expression of matrix metalloproteinase 1 in HaCaT keratinocytes is correlated with the inability to induce mitogen-activated protein family kinases...

Por Sudbeck, B D, Baumann, P, Ryan, G J, Breitkopf, K, Nischt, R, Krieg, T, Mauch, C
Publicado em 1999

Epidermal Snail expression drives skin cancer initiation and progression through enhanced cytoprotection, epidermal stem/progenitor cell expansion and enhanced metastatic potential

Por De Craene, B, Denecker, G, Vermassen, P, Taminau, J, Mauch, C, Derore, A, Jonkers, J, Fuchs, E, Berx, G
Publicado em 2014

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome

Por Hassel, J C, Sucker, A, Edler, L, Kurzen, H, Moll, I, Stresemann, C, Spieth, K, Mauch, C, Rass, K, Dummer, R, Schadendorf, D
Publicado em 2010

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial

Por Urbonas, V, Schadendorf, D, Zimmer, L, Danson, S, Marshall, E, Corrie, P, Wheater, M, Plummer, E, Mauch, C, Scudder, C, Goff, M, Love, S B, Mohammed, S B, Middleton, M R
Publicado no Ann Oncol (2019)